Literature DB >> 22575063

Constant challenges and evolution of US military transfusion medicine and blood operations in combat.

Philip C Spinella1, James Dunne, Greg J Beilman, Robert J O'Connell, Matthew A Borgman, Andrew P Cap, Francisco Rentas.   

Abstract

BACKGROUND: Blood operations are constrained by many limitations in combat settings. As a result there are many challenges that require innovative solutions. STUDY DESIGN AND METHODS: This is a descriptive overview of blood product usage and transfusion medicine adaptations that have been employed by the US military to support combat operations in Iraq and Afghanistan between November 2001 and December 2010.
RESULTS: Transfusion medicine challenges have included the need for rapid transport of large quantities of blood products from the United States to Iraq and Afghanistan, risks and appropriate countermeasures associated with blood products collected in the theater of operations, availability of fresh-frozen plasma at forward surgical facilities, need for platelets (PLTs) in combat, and the need to support constant and evolving changes in transfusion and resuscitation protocols. A decrease in the storage age of red blood cells (RBCs) transfused to combat casualties has been achieved. There has been an increase in the ratio of plasma and PLTs to RBCs transfused, increased availability of plasma and apheresis PLTs to facilitate this approach, and a continuous effort to improve the safety of using fresh whole blood and apheresis PLTs collected in combat. A number of clinical practice guidelines are in place to address these processes.
CONCLUSION: This multidisciplinary approach has successfully addressed many complicated and challenging issues regarding blood operations and transfusion practices for combat casualties.
© 2012 American Association of Blood Banks.

Mesh:

Year:  2012        PMID: 22575063     DOI: 10.1111/j.1537-2995.2012.03594.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  18 in total

1.  In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.

Authors:  M Shukla; U D S Sekhon; V Betapudi; W Li; D A Hickman; C L Pawlowski; M R Dyer; M D Neal; K R McCrae; A Sen Gupta
Journal:  J Thromb Haemost       Date:  2017-02       Impact factor: 5.824

2.  Infrastructure and clinical practice for the detection and management of trauma-associated haemorrhage and coagulopathy.

Authors:  A Driessen; N Schäfer; V Albrecht; M Schenk; M Fröhlich; E K Stürmer; M Maegele
Journal:  Eur J Trauma Emerg Surg       Date:  2014-10-25       Impact factor: 3.693

3.  2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.

Authors:  Anirban Sen Gupta
Journal:  Shock       Date:  2017-09-29       Impact factor: 3.454

4.  Intravenous administration of synthetic platelets (SynthoPlate) in a mouse liver injury model of uncontrolled hemorrhage improves hemostasis.

Authors:  Mitchell R Dyer; DaShawn Hickman; Norman Luc; Shannon Haldeman; Patricia Loughran; Christa Pawlowski; Anirban Sen Gupta; Matthew D Neal
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

Review 5.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

Review 6.  Bioinspired artificial platelets: past, present and future.

Authors:  Norman F Luc; Nathan Rohner; Aditya Girish; Ujjal Didar Singh Sekhon; Matthew D Neal; Anirban Sen Gupta
Journal:  Platelets       Date:  2021-08-30       Impact factor: 3.862

7.  Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding.

Authors:  Ujjal Didar Singh Sekhon; Kelsey Swingle; Aditya Girish; Norman Luc; Maria de la Fuente; Jurgis Alvikas; Shannon Haldeman; Adnan Hassoune; Kaisal Shah; Youjoung Kim; Steven Eppell; Jeffrey Capadona; Andrew Shoffstall; Matthew D Neal; Wei Li; Marvin Nieman; Anirban Sen Gupta
Journal:  Sci Transl Med       Date:  2022-01-26       Impact factor: 19.319

Review 8.  Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.

Authors:  DaShawn A Hickman; Christa L Pawlowski; Ujjal D S Sekhon; Joyann Marks; Anirban Sen Gupta
Journal:  Adv Mater       Date:  2017-11-22       Impact factor: 30.849

9.  Primary hemostatic capacity of whole blood: a comprehensive analysis of pathogen reduction and refrigeration effects over time.

Authors:  Heather F Pidcoke; Steve J McFaul; Anand K Ramasubramanian; Bijaya K Parida; Alex G Mora; Chriselda G Fedyk; Krystal K Valdez-Delgado; Robbie K Montgomery; Kristin M Reddoch; Armando C Rodriguez; James K Aden; John A Jones; Ron S Bryant; Michael R Scherer; Heather L Reddy; Raymond P Goodrich; Andrew P Cap
Journal:  Transfusion       Date:  2013-01       Impact factor: 3.157

10.  Engineering Intravenously Administered Nanoparticles to Reduce Infusion Reaction and Stop Bleeding in a Large Animal Model of Trauma.

Authors:  Chimdiya Onwukwe; Nuzhat Maisha; Mark Holland; Matt Varley; Rebecca Groynom; DaShawn Hickman; Nishant Uppal; Andrew Shoffstall; Jeffrey Ustin; Erin Lavik
Journal:  Bioconjug Chem       Date:  2018-07-09       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.